Enacted — Signed by the President — Jun 29, 2015
Last Action: Signed by President.
Explanation: This bill was enacted after being signed by the President on June 29, 2015.
Jul 19, 1983
98th Congress, 1983–1984
This bill was introduced in a previous session of Congress and was passed by the House on September 6, 1984 but was never passed by the Senate.
Representative for California's 24th congressional district
A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize an abbreviated new drug application under section 505 of that Act for generic new drugs equivalent to approved new drugs.
The “H.R.” in “H.R. 3605” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
The committee chair determines whether a bill will move past the committee stage.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 3605 — 98th Congress: Drug Price Competition and Patent Term Restoration Act of 1984. Retrieved from https://www.govtrack.us/congress/bills/98/hr3605
“H.R. 3605 — 98th Congress: Drug Price Competition and Patent Term Restoration Act of 1984.” www.GovTrack.us. 1983. July 3, 2015 <https://www.govtrack.us/congress/bills/98/hr3605>
|title=H.R. 3605 (98th)
|accessdate=July 3, 2015
|author=98th Congress (1983)
|date=July 19, 1983
|quote=Drug Price Competition and Patent Term Restoration Act of 1984